Moolec Science SA

How big is Moolec Science SA?

As of Jun 18, Moolec Science SA has a market capitalization of 27.47 million, with net sales of 7.83 million and a net profit of -8.29 million over the latest four quarters. As of Jun 24, shareholder's funds are 6.82 million and total assets are 34.79 million.

As of Jun 18, Moolec Science SA has a market capitalization of 27.47 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 7.83 million, while the sum of Net Profit for the same period is -8.29 million.<BR><BR>As of Jun 24, the reporting period shows Shareholder's Funds at 6.82 million and Total Assets at 34.79 million.

What does Moolec Science SA do?

Moolec Science SA is a micro-cap company in the miscellaneous industry, reporting net sales of $3 million and a net loss of $2 million as of December 2024. It has a market cap of $27.47 million and key metrics indicate a high debt-to-equity ratio and negative return on equity.

Overview:<BR>Moolec Science SA operates in the miscellaneous industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 3 Million (Quarterly Results - Dec 2024) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Dec 2024) <BR>Market-cap: USD 27.47 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 7.15 <BR>Return on Equity: -294.74% <BR>Price to Book: 9.82 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Should I buy, sell or hold Moolec Science SA?

Is Moolec Science SA overvalued or undervalued?

As of December 14, 2023, Moolec Science SA is considered risky and overvalued due to troubling financial ratios, including a Price to Book Value of 9.90 and a ROCE of -45.51%, which indicate significant inefficiencies and losses compared to its peers, while its stock has underperformed the S&P 500 with a 1Y return of -37.32%.

As of 14 December 2023, Moolec Science SA's valuation grade has moved from does not qualify to risky, indicating a significant shift in its financial outlook. The company is currently assessed as overvalued, primarily due to its troubling financial ratios. The Price to Book Value stands at 9.90, while the EV to Sales ratio is at 6.09, both of which suggest that the company's market valuation is not justified by its underlying assets or sales performance. Additionally, the ROCE is a concerning -45.51%, and the ROE is alarmingly at -294.74%, reflecting severe inefficiencies and losses.<BR><BR>In comparison with its peers, Moolec's P/E ratio is not applicable due to its loss-making status, while Bit Digital, Inc. has a P/E of -6.38, and Absci Corp. shows a P/E of -3.22, indicating that Moolec is not alone in its struggles. However, the high valuation metrics relative to these peers suggest that Moolec is priced too high given its financial performance. The company's stock has underperformed significantly against the S&P 500 over various time frames, including a 1Y return of -37.32% compared to the index's 10.26%, further reinforcing the view that it is overvalued in the current market environment.

Is Moolec Science SA technically bullish or bearish?

As of August 20, 2025, Moolec Science SA is in a bearish trend with weak momentum, underperforming the S&P 500 by -85.0% year-to-date, despite some bullish signals from the weekly RSI.

As of 20 August 2025, the technical trend for Moolec Science SA has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the weekly MACD and KST both being bearish, and the daily moving averages also signaling bearishness. The Bollinger Bands are bearish on both weekly and monthly time frames. Although the weekly RSI shows bullishness, the overall monthly indicators do not support a strong bullish case. <BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -85.0% versus the S&P 500's 12.22%.